Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Response of Steroid-Refractory Acute GVHD to α1-Antitrypsin.

Marcondes AM, Hockenbery D, Lesnikova M, Dinarello CA, Woolfrey A, Gernsheimer T, Loghman-Adham M, Gelmont D, Storer B, Hansen JA, Deeg HJ.

Biol Blood Marrow Transplant. 2016 Sep;22(9):1596-1601. doi: 10.1016/j.bbmt.2016.05.011. Epub 2016 May 17.

2.

A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation.

Khandelwal P, Emoto C, Fukuda T, Vinks AA, Neumeier L, Dandoy CE, El-Bietar J, Chandra S, Davies SM, Bleesing JJ, Jordan MB, Mehta PA, Jodele S, Grimley MS, Kumar A, Myers KC, Marsh RA.

Biol Blood Marrow Transplant. 2016 Dec;22(12):2220-2225. doi: 10.1016/j.bbmt.2016.09.016. Epub 2016 Sep 21.

3.

Targeting Integrin α4β7 in Steroid-Refractory Intestinal Graft-versus-Host Disease.

Fløisand Y, Lundin KEA, Lazarevic V, Kristiansen JD, Osnes LTN, Tjønnfjord GE, Reims HM, Gedde-Dahl T.

Biol Blood Marrow Transplant. 2017 Jan;23(1):172-175. doi: 10.1016/j.bbmt.2016.10.009. Epub 2016 Oct 21.

4.

α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease.

Magenau JM, Goldstein SC, Peltier D, Soiffer RJ, Braun T, Pawarode A, Riwes MM, Kennel M, Antin JH, Cutler CS, Ho VT, Alyea EP 3rd, Parkin BL, Yanik GA, Choi SW, Lewis EC, Dinarello CA, Koreth J, Reddy P.

Blood. 2018 Mar 22;131(12):1372-1379. doi: 10.1182/blood-2017-11-815746. Epub 2018 Feb 2.

5.

Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFalpha antibody.

Kobbe G, Schneider P, Rohr U, Fenk R, Neumann F, Aivado M, Dietze L, Kronenwett R, Hünerlitürkoglu A, Haas R.

Bone Marrow Transplant. 2001 Jul;28(1):47-9.

6.

α-1-Antitrypsin (AAT)-modified donor cells suppress GVHD but enhance the GVL effect: a role for mitochondrial bioenergetics.

Marcondes AM, Karoopongse E, Lesnikova M, Margineantu D, Welte T, Dinarello CA, Hockenbery D, Janciauskiene S, Deeg HJ.

Blood. 2014 Oct 30;124(18):2881-91. doi: 10.1182/blood-2014-04-570440. Epub 2014 Sep 15.

7.

Etanercept for steroid-refractory acute graft versus host disease following allogeneic hematopoietic stem cell transplantation.

Park JH, Lee HJ, Kim SR, Song GW, Lee SK, Park SY, Kim KC, Hwang SH, Park JS.

Korean J Intern Med. 2014 Sep;29(5):630-6. doi: 10.3904/kjim.2014.29.5.630. Epub 2014 Aug 28.

8.

[Anti-CD(25) monoclonal antibody as a salvage therapy for steroid-refractory acute graft-versus-host disease in 80 patients receiving allogeneic hematopoietic stem cell transplantation].

Tao T, Xue SL, Chen F, Xu Y, Ma X, Miao M, Tang XW, Wu DP.

Zhonghua Nei Ke Za Zhi. 2018 May 1;57(5):324-329. doi: 10.3760/cma.j.issn.0578-1426.2018.05.004. Chinese.

PMID:
29747286
9.

Ruxolitinib in steroid refractory graft-vs.-host disease: a case report.

Maffini E, Giaccone L, Festuccia M, Brunello L, Buondonno I, Ferrero D, Boccadoro M, Dellacasa C, Busca A, Novero D, Bruno B.

J Hematol Oncol. 2016 Aug 8;9(1):67. doi: 10.1186/s13045-016-0298-6.

10.
11.

Alpha-1 antitrypsin therapy is safe and well tolerated in children and adolescents with recent onset type 1 diabetes mellitus.

Rachmiel M, Strauss P, Dror N, Benzaquen H, Horesh O, Tov N, Weintrob N, Landau Z, Ben-Ami M, Haim A, Phillip M, Bistritzer T, Lewis EC, Lebenthal Y.

Pediatr Diabetes. 2016 Aug;17(5):351-9. doi: 10.1111/pedi.12283. Epub 2015 Jun 15.

PMID:
26073583
12.

Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study.

Greinix HT, Volc-Platzer B, Kalhs P, Fischer G, Rosenmayr A, Keil F, Hönigsmann H, Knobler RM.

Blood. 2000 Oct 1;96(7):2426-31.

14.

Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Ho VT, Zahrieh D, Hochberg E, Micale E, Levin J, Reynolds C, Steckel S, Cutler C, Fisher DC, Lee SJ, Alyea EP, Ritz J, Soiffer RJ, Antin JH.

Blood. 2004 Aug 15;104(4):1224-6. Epub 2004 Apr 27.

15.

Mesenchymal stromal cells for steroid-refractory acute GvHD.

Fernández-Maqueda C, Gonzalo-Daganzo R, Regidor C, Martín-Donaire T, Sánchez R, Bueno JL, Bautista G, De Liglesia A, Gutiérrez Y, García-Berciano M, Forés R, Royuela A, Fernández MN, Duarte RF, Cabrera-Marín JR.

Bone Marrow Transplant. 2017 Nov;52(11):1577-1579. doi: 10.1038/bmt.2017.177. Epub 2017 Aug 7. No abstract available.

PMID:
28783146
16.

Anti-tumor necrosis factor-a for the treatment of steroid-refractory acute graft-versus-host disease.

Nogueira MC, Azevedo AM, Pereira SC, Ferreira JL, Lerner D, Lobo AM, Tavares RC, Tabak DG, Lorenzi N, Renault IZ, Bouzas LF.

Braz J Med Biol Res. 2007 Dec;40(12):1623-9. Epub 2007 Oct 29.

17.

Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Hematopoietic Stem Cell Transplant Patients.

Khandelwal P, Teusink-Cross A, Davies SM, Nelson AS, Dandoy CE, El-Bietar J, Marsh RA, Kumar AR, Grimley MS, Jodele S, Myers KC.

Biol Blood Marrow Transplant. 2017 Jul;23(7):1122-1127. doi: 10.1016/j.bbmt.2017.03.029. Epub 2017 Mar 23.

18.

Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD.

Perfetti P, Carlier P, Strada P, Gualandi F, Occhini D, Van Lint MT, Ibatici A, Lamparelli T, Bruno B, Raiola AM, Dominietto A, Di Grazia C, Bregante S, Zia S, Ferrari GM, Stura P, Pogliani E, Bacigalupo A.

Bone Marrow Transplant. 2008 Nov;42(9):609-17. doi: 10.1038/bmt.2008.221. Epub 2008 Jul 28.

PMID:
18660840
19.

Steroid-refractory cutaneous graft-versus-host disease after transplantation of haploidentical parental CD34+ cells in children with Down's syndrome and recurrent acute leukemia.

Mogul MJ, Forte KJ, Holland HK, Turner CW, Benyunes MC, Yeager AM.

J Pediatr Hematol Oncol. 1997 Mar-Apr;19(2):142-4.

PMID:
9149745
20.

Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulin.

McCaul KG, Nevill TJ, Barnett MJ, Toze CL, Currie CJ, Sutherland HJ, Conneally EA, Shepherd JD, Nantel SH, Hogge DE, Klingemann HG.

J Hematother Stem Cell Res. 2000 Jun;9(3):367-74.

PMID:
10894358

Supplemental Content

Support Center